[Prevention of tissue hemorrhage following conization of the cervix uteri using antifibrinolytics].
D000287:Administration, Topical; D000328:Adult; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002584:Cervix Uteri / Q000601:surgery; D005260:Female; D005342:Fibrinolysis; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007044:Hysterectomy; D007275:Injections, Intravenous; D008875:Middle Aged; D011183:Postoperative Complications; D013997:Time Factors; D014599:Uterus / Q000032:analysis
D000933:Antifibrinolytic Agents
Prophylaxe der Gewebsblutung nach Konisation der Portio vaginalis uteri mit Hilfe von Antifibrinolytika